Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychiatr Serv 57:175, February 2006
doi: 10.1176/appi.ps.57.2.175
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Larson, M. J.
* Articles by Fleming, K. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Larson, M. J.
* Articles by Fleming, K. J.
Related Collections
* Health Insurance
* Service Utilization
* Other Health Services Issues
* Antidepressants

Columns

Datapoints: Antidepressant Medication Use in Private Insurance Health Plans, 2002

Mary Jo Larson, Ph.D., Kay Miller, B.A. and Kathleen J. Fleming, M.Ed.


  Introduction

 
 TOP
 Introduction
 References
 
Antidepressants are used more commonly than any other form of psychotropic medication. Treatment with antidepressants is increasing while the use of psychotherapy appears to be declining (1,2). Antidepressant use increased by 115 percent between 1993 and 1998 alone (3). However, not all of this increase can be attributed to increased treatment of depression. This study examined the proportion of members of a private health insurance plan who received an antidepressant and the extent to which this use was accompanied by other mental health care.

Data were drawn from Medstat's 2002 MarketScan Database, a convenience sample of more than 5.5 million privately insured employees and their dependents aged 0 to 64 years from the largest U.S. firms, covering a wide range of health plans and employers. Mental health service use was identified by scanning all 2002 claims and encounters for selected diagnoses, provider types, and procedure codes. Antidepressant use was identified from pharmaceutical claims. Mental health service use was defined as a claim with one of the following: a primary or secondary diagnosis of a mental health or substance use disorder, including tobacco addiction; a service provided by a mental health specialist; or a service coded as individual or group counseling or as mental health or substance abuse treatment.

Antidepressant use with or without other mental health service use was common in 2002. Eleven percent of the enrollees received at least one antidepressant during the year (Figure 1).


Figure 1
View larger version (18K):
[in this window]
[in a new window]
 

Figure 1. Antidepressant use (N=609,734), with and without other mental health care, among enrollees of a private insurance health plan in 2002 (N=5,558,788)



A majority of patients who used antidepressants did not receive any other mental health care or a diagnosis of a mental health or substance use disorder. Furthermore, one-fifth of antidepressant users (19.4 percent) did not have any claims for mental health care and had one of several medical conditions known to be associated with off-label use of antidepressants. These findings suggest that, to some degree, analyses that assume that all antidepressant users receive treatment for a mental health condition may overstate the number of people who are reached by the mental health system. Research should investigate the basis on which providers are choosing to prescribe an antidepressant when no other apparent mental health care is delivered.


  Acknowledgments

 
The authors thank Judith Teich, M.S.W., and Jeff Buck, Ph.D. The project was funded by contract 03-M000-1880-1D from the Center for Mental Health Services.


  Footnotes

 
Dr. Larson and Ms. Fleming are affiliated with the Institute for Health Services Research and Policy at New England Research Institutes, 9 Galen Street, Watertown, Massachusetts 02474 (e-mail, mjlarson{at}neriscience.com). Ms. Miller is with Medstat in Santa Barbara, California. Harold Alan Pincus, M.D., Terri L. Tanielian, M.A., and Amy M. Kilbourne, Ph.D., M.P.H., are editors of this column.


  References

 
 TOP
 Introduction
 References
 

  1. Olfson M, Marcus SC, Druss B, et al: National trends in the outpatient treatment of depression. JAMA 287:203–209,2002[Abstract/Free Full Text]
  2. Zuvekas SH: Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001. Health Affairs 24(1):195–205,2005
  3. Factors affecting the growth of prescription drug expenditures. Washington, DC, Barents Group LLC, National Institute for Health Care Management Research and Educational Foundation, 1999




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Larson, M. J.
* Articles by Fleming, K. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Larson, M. J.
* Articles by Fleming, K. J.
Related Collections
* Health Insurance
* Service Utilization
* Other Health Services Issues
* Antidepressants


Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org